Listed

Teladoc Health, Inc.

TDOCNYSECIK 1477449HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$606.9m, Q2 FY2026
Operating income−$37.1m, Q2 FY2026
Net income−$38.9m, Q2 FY2026
Teladoc Health, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m660Revenue, Q3 FY2023, three months to 2023-09-30$660.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-10-31, accession 0001477449-24-000225.Report this figure661Revenue, Q4 FY2023, three months to 2023-12-31$660.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-26, accession 0001477449-26-000012. Derived: 12-month figure less the 9-month figure.Report this figure646Revenue, Q1 FY2024, three months to 2024-03-31$646.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-01, accession 0001477449-25-000049.Report this figure642Revenue, Q2 FY2024, three months to 2024-06-30$642.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-07-30, accession 0001477449-25-000099.Report this figure641Revenue, Q3 FY2024, three months to 2024-09-30$640.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-30, accession 0001477449-25-000120.Report this figure640Revenue, Q4 FY2024, three months to 2024-12-31$640.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-26, accession 0001477449-26-000012. Derived: 12-month figure less the 9-month figure.Report this figure629Revenue, Q1 FY2025, three months to 2025-03-31$629.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-30, accession 0001477449-26-000028.Report this figure632Revenue, Q2 FY2025, three months to 2025-06-30$631.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-30, accession 0001477449-26-000038.Report this figure626Revenue, Q3 FY2025, three months to 2025-09-30$626.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-30, accession 0001477449-25-000120.Report this figure642Revenue, Q4 FY2025, three months to 2025-12-31$642.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-26, accession 0001477449-26-000012. Derived: 12-month figure less the 9-month figure.Report this figure614Revenue, Q1 FY2026, three months to 2026-03-31$613.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-30, accession 0001477449-26-000028.Report this figure607Revenue, Q2 FY2026, three months to 2026-06-30$606.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-30, accession 0001477449-26-000038.Report this figure
Cost of revenue$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Gross profit$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Research and development$m84.3Research and development, Q3 FY2023, three months to 2023-09-30$84.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-10-31, accession 0001477449-24-000225.Report this figure89.9Research and development, Q4 FY2023, three months to 2023-12-31$89.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-26, accession 0001477449-26-000012. Derived: 12-month figure less the 9-month figure.Report this figure81.4Research and development, Q1 FY2024, three months to 2024-03-31$81.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-01, accession 0001477449-25-000049.Report this figure76.8Research and development, Q2 FY2024, three months to 2024-06-30$76.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-07-30, accession 0001477449-25-000099.Report this figure72.4Research and development, Q3 FY2024, three months to 2024-09-30$72.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-10-30, accession 0001477449-25-000120.Report this figure76.8Research and development, Q4 FY2024, three months to 2024-12-31$76.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-26, accession 0001477449-26-000012. Derived: 12-month figure less the 9-month figure.Report this figure70.0Research and development, Q1 FY2025, three months to 2025-03-31$70.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-04-30, accession 0001477449-26-000028.Report this figure68.8Research and development, Q2 FY2025, three months to 2025-06-30$68.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-07-30, accession 0001477449-26-000038.Report this figure67.6Research and development, Q3 FY2025, three months to 2025-09-30$67.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-10-30, accession 0001477449-25-000120.Report this figure71.6Research and development, Q4 FY2025, three months to 2025-12-31$71.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-26, accession 0001477449-26-000012. Derived: 12-month figure less the 9-month figure.Report this figure67.9Research and development, Q1 FY2026, three months to 2026-03-31$67.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-04-30, accession 0001477449-26-000028.Report this figure62.9Research and development, Q2 FY2026, three months to 2026-06-30$62.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-07-30, accession 0001477449-26-000038.Report this figure
Operating income$m(64.7)Operating income, Q3 FY2023, three months to 2023-09-30−$64.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-10-31, accession 0001477449-24-000225.Report this figure(35.1)Operating income, Q4 FY2023, three months to 2023-12-31−$35.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001477449-26-000012. Derived: 12-month figure less the 9-month figure.Report this figure(87.1)Operating income, Q1 FY2024, three months to 2024-03-31−$87.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-01, accession 0001477449-25-000049.Report this figure(841)Operating income, Q2 FY2024, three months to 2024-06-30−$841.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-07-30, accession 0001477449-25-000099.Report this figure(44.4)Operating income, Q3 FY2024, three months to 2024-09-30−$44.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-10-30, accession 0001477449-25-000120.Report this figure(48.2)Operating income, Q4 FY2024, three months to 2024-12-31−$48.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001477449-26-000012. Derived: 12-month figure less the 9-month figure.Report this figure(121)Operating income, Q1 FY2025, three months to 2025-03-31−$120.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-04-30, accession 0001477449-26-000028.Report this figure(54.4)Operating income, Q2 FY2025, three months to 2025-06-30−$54.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-30, accession 0001477449-26-000038.Report this figure(52.0)Operating income, Q3 FY2025, three months to 2025-09-30−$52.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-10-30, accession 0001477449-25-000120.Report this figure(36.0)Operating income, Q4 FY2025, three months to 2025-12-31−$36.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001477449-26-000012. Derived: 12-month figure less the 9-month figure.Report this figure(61.8)Operating income, Q1 FY2026, three months to 2026-03-31−$61.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-04-30, accession 0001477449-26-000028.Report this figure(37.1)Operating income, Q2 FY2026, three months to 2026-06-30−$37.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-30, accession 0001477449-26-000038.Report this figure
Interest expense$m5.6Interest expense, Q3 FY2023, three months to 2023-09-30$5.6m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-10-31, accession 0001477449-24-000225.Report this figure5.5Interest expense, Q4 FY2023, three months to 2023-12-31$5.5m. XBRL concept us-gaap:InterestExpense. 10-K filed 2025-02-27, accession 0001477449-25-000005. Derived: 12-month figure less the 9-month figure.Report this figure5.6Interest expense, Q1 FY2024, three months to 2024-03-31$5.6m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-05-01, accession 0001477449-25-000049.Report this figure5.6Interest expense, Q2 FY2024, three months to 2024-06-30$5.6m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-08-01, accession 0001477449-24-000174.Report this figure5.7Interest expense, Q3 FY2024, three months to 2024-09-30$5.7m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-10-31, accession 0001477449-24-000225.Report this figure6.8Interest expense, Q4 FY2024, three months to 2024-12-31$6.8m. XBRL concept us-gaap:InterestExpense. 10-K filed 2025-02-27, accession 0001477449-25-000005. Derived: 12-month figure less the 9-month figure.Report this figure5.8Interest expense, Q1 FY2025, three months to 2025-03-31$5.8m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-05-01, accession 0001477449-25-000049.Report this figure4.5Interest expense, Q2 FY2025, three months to 2025-06-30$4.5m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-07-30, accession 0001477449-26-000038.Report this figure4.5Interest expense, Q3 FY2025, three months to 2025-09-30$4.5m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-10-30, accession 0001477449-25-000120.Report this figure5.0Interest expense, Q4 FY2025, three months to 2025-12-31$5.0m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-26, accession 0001477449-26-000012. Derived: 12-month figure less the 9-month figure.Report this figure5.4Interest expense, Q1 FY2026, three months to 2026-03-31$5.4m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-04-30, accession 0001477449-26-000028.Report this figure5.1Interest expense, Q2 FY2026, three months to 2026-06-30$5.1m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-07-30, accession 0001477449-26-000038.Report this figure
Income tax$m(2.5)Income tax, Q3 FY2023, three months to 2023-09-30−$2.5m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-10-31, accession 0001477449-24-000225.Report this figure3.5Income tax, Q4 FY2023, three months to 2023-12-31$3.5m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-26, accession 0001477449-26-000012. Derived: 12-month figure less the 9-month figure.Report this figure2.7Income tax, Q1 FY2024, three months to 2024-03-31$2.7m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-01, accession 0001477449-25-000049.Report this figure3.9Income tax, Q2 FY2024, three months to 2024-06-30$3.9m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-07-30, accession 0001477449-25-000099.Report this figure0.8Income tax, Q3 FY2024, three months to 2024-09-30$780.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-10-30, accession 0001477449-25-000120.Report this figure0.2Income tax, Q4 FY2024, three months to 2024-12-31$238.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-26, accession 0001477449-26-000012. Derived: 12-month figure less the 9-month figure.Report this figure(18.3)Income tax, Q1 FY2025, three months to 2025-03-31−$18.3m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-04-30, accession 0001477449-26-000028.Report this figure(7.8)Income tax, Q2 FY2025, three months to 2025-06-30−$7.8m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-07-30, accession 0001477449-26-000038.Report this figure(0.7)Income tax, Q3 FY2025, three months to 2025-09-30−$715.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-10-30, accession 0001477449-25-000120.Report this figure(8.5)Income tax, Q4 FY2025, three months to 2025-12-31−$8.5m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-26, accession 0001477449-26-000012. Derived: 12-month figure less the 9-month figure.Report this figure3.0Income tax, Q1 FY2026, three months to 2026-03-31$3.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-04-30, accession 0001477449-26-000028.Report this figure1.0Income tax, Q2 FY2026, three months to 2026-06-30$997.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-07-30, accession 0001477449-26-000038.Report this figure
Net income$m(57.1)Net income, Q3 FY2023, three months to 2023-09-30−$57.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-10-31, accession 0001477449-24-000225.Report this figure(28.9)Net income, Q4 FY2023, three months to 2023-12-31−$28.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001477449-26-000012. Derived: 12-month figure less the 9-month figure.Report this figure(81.9)Net income, Q1 FY2024, three months to 2024-03-31−$81.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-01, accession 0001477449-25-000049.Report this figure(838)Net income, Q2 FY2024, three months to 2024-06-30−$837.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-07-30, accession 0001477449-25-000099.Report this figure(33.3)Net income, Q3 FY2024, three months to 2024-09-30−$33.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-30, accession 0001477449-25-000120.Report this figure(48.4)Net income, Q4 FY2024, three months to 2024-12-31−$48.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001477449-26-000012. Derived: 12-month figure less the 9-month figure.Report this figure(93.0)Net income, Q1 FY2025, three months to 2025-03-31−$93.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-04-30, accession 0001477449-26-000028.Report this figure(32.7)Net income, Q2 FY2025, three months to 2025-06-30−$32.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-30, accession 0001477449-26-000038.Report this figure(49.5)Net income, Q3 FY2025, three months to 2025-09-30−$49.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-30, accession 0001477449-25-000120.Report this figure(25.1)Net income, Q4 FY2025, three months to 2025-12-31−$25.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001477449-26-000012. Derived: 12-month figure less the 9-month figure.Report this figure(63.8)Net income, Q1 FY2026, three months to 2026-03-31−$63.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-04-30, accession 0001477449-26-000028.Report this figure(38.9)Net income, Q2 FY2026, three months to 2026-06-30−$38.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-30, accession 0001477449-26-000038.Report this figure
Diluted EPS$ per share(0.35)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.35 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-10-31, accession 0001477449-24-000225.Report this figurenot reported(0.49)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.49 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-01, accession 0001477449-25-000049.Report this figure(4.92)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$4.92 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-07-30, accession 0001477449-25-000099.Report this figure(0.19)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.19 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-10-30, accession 0001477449-25-000120.Report this figurenot reported(0.53)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.53 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-30, accession 0001477449-26-000028.Report this figure(0.19)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.19 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-30, accession 0001477449-26-000038.Report this figure(0.28)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.28 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-10-30, accession 0001477449-25-000120.Report this figurenot reported(0.36)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.36 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-30, accession 0001477449-26-000028.Report this figure(0.21)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.21 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-30, accession 0001477449-26-000038.Report this figure
Basic EPS$ per share(0.35)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.35 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-10-31, accession 0001477449-24-000225.Report this figurenot reported(0.49)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.49 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-01, accession 0001477449-25-000049.Report this figure(4.92)Basic EPS, Q2 FY2024, three months to 2024-06-30−$4.92 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-07-30, accession 0001477449-25-000099.Report this figure(0.19)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.19 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-10-30, accession 0001477449-25-000120.Report this figurenot reported(0.53)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.53 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-04-30, accession 0001477449-26-000028.Report this figure(0.19)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.19 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-07-30, accession 0001477449-26-000038.Report this figure(0.28)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.28 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-10-30, accession 0001477449-25-000120.Report this figurenot reported(0.36)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.36 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-04-30, accession 0001477449-26-000028.Report this figure(0.21)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.21 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-07-30, accession 0001477449-26-000038.Report this figure

Balance sheet

Cash and equivalents$774.3m, Q2 FY2026
Shareholders' equity$1.31bn, Q2 FY2026
Teladoc Health, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m1,031Cash and equivalents, Q3 FY2023, at 2023-09-30$1.03bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-10-27, accession 0001477449-23-000066.Report this figure1,124Cash and equivalents, FY2023, at 2023-12-31$1.12bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-02-27, accession 0001477449-25-000005.Report this figure1,098Cash and equivalents, Q1 FY2024, at 2024-03-31$1.10bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-04-26, accession 0001477449-24-000101.Report this figure1,162Cash and equivalents, Q2 FY2024, at 2024-06-30$1.16bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-01, accession 0001477449-24-000174.Report this figure1,244Cash and equivalents, Q3 FY2024, at 2024-09-30$1.24bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-10-31, accession 0001477449-24-000225.Report this figure1,298Cash and equivalents, FY2024, at 2024-12-31$1.30bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-26, accession 0001477449-26-000012.Report this figure1,193Cash and equivalents, Q1 FY2025, at 2025-03-31$1.19bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-01, accession 0001477449-25-000049.Report this figure680Cash and equivalents, Q2 FY2025, at 2025-06-30$679.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-07-30, accession 0001477449-25-000099.Report this figure726Cash and equivalents, Q3 FY2025, at 2025-09-30$726.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-10-30, accession 0001477449-25-000120.Report this figure781Cash and equivalents, FY2025, at 2025-12-31$781.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-07-30, accession 0001477449-26-000038.Report this figure751Cash and equivalents, Q1 FY2026, at 2026-03-31$750.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-04-30, accession 0001477449-26-000028.Report this figure774Cash and equivalents, Q2 FY2026, at 2026-06-30$774.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-07-30, accession 0001477449-26-000038.Report this figure
Current assets$m1,387Current assets, Q3 FY2023, at 2023-09-30$1.39bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-10-27, accession 0001477449-23-000066.Report this figure1,489Current assets, FY2023, at 2023-12-31$1.49bn. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-02-27, accession 0001477449-25-000005.Report this figure1,486Current assets, Q1 FY2024, at 2024-03-31$1.49bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-04-26, accession 0001477449-24-000101.Report this figure1,547Current assets, Q2 FY2024, at 2024-06-30$1.55bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-01, accession 0001477449-24-000174.Report this figure1,609Current assets, Q3 FY2024, at 2024-09-30$1.61bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-10-31, accession 0001477449-24-000225.Report this figure1,664Current assets, FY2024, at 2024-12-31$1.66bn. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-26, accession 0001477449-26-000012.Report this figure1,602Current assets, Q1 FY2025, at 2025-03-31$1.60bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-01, accession 0001477449-25-000049.Report this figure1,073Current assets, Q2 FY2025, at 2025-06-30$1.07bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-07-30, accession 0001477449-25-000099.Report this figure1,093Current assets, Q3 FY2025, at 2025-09-30$1.09bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-10-30, accession 0001477449-25-000120.Report this figure1,119Current assets, FY2025, at 2025-12-31$1.12bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-07-30, accession 0001477449-26-000038.Report this figure1,132Current assets, Q1 FY2026, at 2026-03-31$1.13bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-04-30, accession 0001477449-26-000028.Report this figure1,148Current assets, Q2 FY2026, at 2026-06-30$1.15bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-07-30, accession 0001477449-26-000038.Report this figure
Total assets$m4,328Total assets, Q3 FY2023, at 2023-09-30$4.33bn. XBRL concept us-gaap:Assets. 10-Q filed 2023-10-27, accession 0001477449-23-000066.Report this figure4,392Total assets, FY2023, at 2023-12-31$4.39bn. XBRL concept us-gaap:Assets. 10-K filed 2025-02-27, accession 0001477449-25-000005.Report this figure4,321Total assets, Q1 FY2024, at 2024-03-31$4.32bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-04-26, accession 0001477449-24-000101.Report this figure3,524Total assets, Q2 FY2024, at 2024-06-30$3.52bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-01, accession 0001477449-24-000174.Report this figure3,529Total assets, Q3 FY2024, at 2024-09-30$3.53bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-10-31, accession 0001477449-24-000225.Report this figure3,517Total assets, FY2024, at 2024-12-31$3.52bn. XBRL concept us-gaap:Assets. 10-K filed 2026-02-26, accession 0001477449-26-000012.Report this figure3,444Total assets, Q1 FY2025, at 2025-03-31$3.44bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-01, accession 0001477449-25-000049.Report this figure2,894Total assets, Q2 FY2025, at 2025-06-30$2.89bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-07-30, accession 0001477449-25-000099.Report this figure2,879Total assets, Q3 FY2025, at 2025-09-30$2.88bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-10-30, accession 0001477449-25-000120.Report this figure2,858Total assets, FY2025, at 2025-12-31$2.86bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-07-30, accession 0001477449-26-000038.Report this figure2,807Total assets, Q1 FY2026, at 2026-03-31$2.81bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-04-30, accession 0001477449-26-000028.Report this figure2,759Total assets, Q2 FY2026, at 2026-06-30$2.76bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-07-30, accession 0001477449-26-000038.Report this figure
Current liabilities$m403Current liabilities, Q3 FY2023, at 2023-09-30$402.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-10-27, accession 0001477449-23-000066.Report this figure421Current liabilities, FY2023, at 2023-12-31$420.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-02-27, accession 0001477449-25-000005.Report this figure389Current liabilities, Q1 FY2024, at 2024-03-31$388.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-04-26, accession 0001477449-24-000101.Report this figure931Current liabilities, Q2 FY2024, at 2024-06-30$930.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-01, accession 0001477449-24-000174.Report this figure931Current liabilities, Q3 FY2024, at 2024-09-30$931.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-10-31, accession 0001477449-24-000225.Report this figure942Current liabilities, FY2024, at 2024-12-31$941.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-26, accession 0001477449-26-000012.Report this figure952Current liabilities, Q1 FY2025, at 2025-03-31$952.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-01, accession 0001477449-25-000049.Report this figure402Current liabilities, Q2 FY2025, at 2025-06-30$401.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-07-30, accession 0001477449-25-000099.Report this figure405Current liabilities, Q3 FY2025, at 2025-09-30$405.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-10-30, accession 0001477449-25-000120.Report this figure405Current liabilities, FY2025, at 2025-12-31$404.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-07-30, accession 0001477449-26-000038.Report this figure405Current liabilities, Q1 FY2026, at 2026-03-31$404.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-04-30, accession 0001477449-26-000028.Report this figure1,382Current liabilities, Q2 FY2026, at 2026-06-30$1.38bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-07-30, accession 0001477449-26-000038.Report this figure
Total liabilities$mnot reported2,066Total liabilities, FY2023, at 2023-12-31$2.07bn. XBRL concept us-gaap:Liabilities. 10-K filed 2025-02-27, accession 0001477449-25-000005.Report this figurenot reported2,022Total liabilities, Q2 FY2024, at 2024-06-30$2.02bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-01, accession 0001477449-24-000174.Report this figure2,021Total liabilities, Q3 FY2024, at 2024-09-30$2.02bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-10-31, accession 0001477449-24-000225.Report this figure2,025Total liabilities, FY2024, at 2024-12-31$2.03bn. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-26, accession 0001477449-26-000012.Report this figure2,017Total liabilities, Q1 FY2025, at 2025-03-31$2.02bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-01, accession 0001477449-25-000049.Report this figure1,472Total liabilities, Q2 FY2025, at 2025-06-30$1.47bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-07-30, accession 0001477449-25-000099.Report this figure1,486Total liabilities, Q3 FY2025, at 2025-09-30$1.49bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-10-30, accession 0001477449-25-000120.Report this figure1,473Total liabilities, FY2025, at 2025-12-31$1.47bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-07-30, accession 0001477449-26-000038.Report this figure1,471Total liabilities, Q1 FY2026, at 2026-03-31$1.47bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-04-30, accession 0001477449-26-000028.Report this figure1,449Total liabilities, Q2 FY2026, at 2026-06-30$1.45bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-07-30, accession 0001477449-26-000038.Report this figure
Long-term debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Current portion of debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m2,294Shareholders' equity, Q3 FY2023, at 2023-09-30$2.29bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-10-31, accession 0001477449-24-000225.Report this figure2,326Shareholders' equity, FY2023, at 2023-12-31$2.33bn. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-26, accession 0001477449-26-000012.Report this figure2,289Shareholders' equity, Q1 FY2024, at 2024-03-31$2.29bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-07-30, accession 0001477449-25-000099.Report this figure1,502Shareholders' equity, Q2 FY2024, at 2024-06-30$1.50bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-30, accession 0001477449-25-000120.Report this figure1,508Shareholders' equity, Q3 FY2024, at 2024-09-30$1.51bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-30, accession 0001477449-25-000120.Report this figure1,491Shareholders' equity, FY2024, at 2024-12-31$1.49bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-30, accession 0001477449-26-000038.Report this figure1,427Shareholders' equity, Q1 FY2025, at 2025-03-31$1.43bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-30, accession 0001477449-26-000038.Report this figure1,422Shareholders' equity, Q2 FY2025, at 2025-06-30$1.42bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-30, accession 0001477449-26-000038.Report this figure1,392Shareholders' equity, Q3 FY2025, at 2025-09-30$1.39bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-30, accession 0001477449-25-000120.Report this figure1,386Shareholders' equity, FY2025, at 2025-12-31$1.39bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-30, accession 0001477449-26-000038.Report this figure1,336Shareholders' equity, Q1 FY2026, at 2026-03-31$1.34bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-30, accession 0001477449-26-000038.Report this figure1,310Shareholders' equity, Q2 FY2026, at 2026-06-30$1.31bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-30, accession 0001477449-26-000038.Report this figure

Cash flow

Operating cash flow$64.7m, Q2 FY2026
Capital expenditure$928.0k, Q2 FY2026
Teladoc Health, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m106Operating cash flow, Q3 FY2023, three months to 2023-09-30$105.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-10-31, accession 0001477449-24-000225. Derived: 9-month figure less the 6-month figure.Report this figure130Operating cash flow, Q4 FY2023, three months to 2023-12-31$130.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001477449-26-000012. Derived: 12-month figure less the 9-month figure.Report this figure8.9Operating cash flow, Q1 FY2024, three months to 2024-03-31$8.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-01, accession 0001477449-25-000049.Report this figure88.7Operating cash flow, Q2 FY2024, three months to 2024-06-30$88.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-07-30, accession 0001477449-25-000099. Derived: 6-month figure less the 3-month figure.Report this figure110Operating cash flow, Q3 FY2024, three months to 2024-09-30$110.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-10-30, accession 0001477449-25-000120. Derived: 9-month figure less the 6-month figure.Report this figure85.9Operating cash flow, Q4 FY2024, three months to 2024-12-31$85.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001477449-26-000012. Derived: 12-month figure less the 9-month figure.Report this figure15.9Operating cash flow, Q1 FY2025, three months to 2025-03-31$15.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-30, accession 0001477449-26-000028.Report this figure91.4Operating cash flow, Q2 FY2025, three months to 2025-06-30$91.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-30, accession 0001477449-26-000038. Derived: 6-month figure less the 3-month figure.Report this figure99.3Operating cash flow, Q3 FY2025, three months to 2025-09-30$99.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-10-30, accession 0001477449-25-000120. Derived: 9-month figure less the 6-month figure.Report this figure87.7Operating cash flow, Q4 FY2025, three months to 2025-12-31$87.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001477449-26-000012. Derived: 12-month figure less the 9-month figure.Report this figure9.5Operating cash flow, Q1 FY2026, three months to 2026-03-31$9.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-30, accession 0001477449-26-000028.Report this figure64.7Operating cash flow, Q2 FY2026, three months to 2026-06-30$64.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-30, accession 0001477449-26-000038. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m5.8Capital expenditure, Q3 FY2023, three months to 2023-09-30$5.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-10-31, accession 0001477449-24-000225. Derived: 9-month figure less the 6-month figure.Report this figure1.4Capital expenditure, Q4 FY2023, three months to 2023-12-31$1.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-26, accession 0001477449-26-000012. Derived: 12-month figure less the 9-month figure.Report this figure1.1Capital expenditure, Q1 FY2024, three months to 2024-03-31$1.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-01, accession 0001477449-25-000049.Report this figure1.9Capital expenditure, Q2 FY2024, three months to 2024-06-30$1.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-07-30, accession 0001477449-25-000099. Derived: 6-month figure less the 3-month figure.Report this figure1.6Capital expenditure, Q3 FY2024, three months to 2024-09-30$1.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-10-30, accession 0001477449-25-000120. Derived: 9-month figure less the 6-month figure.Report this figure6.1Capital expenditure, Q4 FY2024, three months to 2024-12-31$6.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-26, accession 0001477449-26-000012. Derived: 12-month figure less the 9-month figure.Report this figure2.7Capital expenditure, Q1 FY2025, three months to 2025-03-31$2.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-04-30, accession 0001477449-26-000028.Report this figure1.3Capital expenditure, Q2 FY2025, three months to 2025-06-30$1.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-30, accession 0001477449-26-000038. Derived: 6-month figure less the 3-month figure.Report this figure2.3Capital expenditure, Q3 FY2025, three months to 2025-09-30$2.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-10-30, accession 0001477449-25-000120. Derived: 9-month figure less the 6-month figure.Report this figure2.6Capital expenditure, Q4 FY2025, three months to 2025-12-31$2.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-26, accession 0001477449-26-000012. Derived: 12-month figure less the 9-month figure.Report this figure1.7Capital expenditure, Q1 FY2026, three months to 2026-03-31$1.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-04-30, accession 0001477449-26-000028.Report this figure0.9Capital expenditure, Q2 FY2026, three months to 2026-06-30$928.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-30, accession 0001477449-26-000038. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)181.03m, Q2 FY2026
Teladoc Health, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares162Diluted shares (weighted), Q3 FY2022, three months to 2022-09-30161,727,962 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-10-27, accession 0001477449-23-000066.Report this figure163Diluted shares (weighted), Q1 FY2023, three months to 2023-03-31162,922,691 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-04-26, accession 0001477449-24-000101.Report this figure164Diluted shares (weighted), Q2 FY2023, three months to 2023-06-30164,171,372 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-01, accession 0001477449-24-000174.Report this figure165Diluted shares (weighted), Q3 FY2023, three months to 2023-09-30165,119,379 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-10-31, accession 0001477449-24-000225.Report this figure168Diluted shares (weighted), Q1 FY2024, three months to 2024-03-31167,730,746 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-01, accession 0001477449-25-000049.Report this figure170Diluted shares (weighted), Q2 FY2024, three months to 2024-06-30170,229,583 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-07-30, accession 0001477449-25-000099.Report this figure171Diluted shares (weighted), Q3 FY2024, three months to 2024-09-30171,496,282 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-10-30, accession 0001477449-25-000120.Report this figure174Diluted shares (weighted), Q1 FY2025, three months to 2025-03-31174,154,128 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-04-30, accession 0001477449-26-000028.Report this figure176Diluted shares (weighted), Q2 FY2025, three months to 2025-06-30175,917,380 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-07-30, accession 0001477449-26-000038.Report this figure177Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30176,934,781 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-10-30, accession 0001477449-25-000120.Report this figure179Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31179,122,268 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-04-30, accession 0001477449-26-000028.Report this figure181Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30181,026,004 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-07-30, accession 0001477449-26-000038.Report this figure

Shares outstanding: 181.68mShares outstanding, period not labelled, at 2026-07-23181,684,021 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-07-30, accession 0001477449-26-000038.Report this figure at Jul 23, 2026, from the cover of the 10-Q filed Jul 30, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:40 ET. Listed shows no prices and gives no investment advice.